Nov 17 (Reuters) – IMPACT Therapeutics, Inc: * EUROPEAN COMMISSION APPROVES SENAPARIB FOR MAINTENANCE TREATMENT OF ADVANCED OVARIAN CANCER Further company coverage:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
VIDEO SHOWS: HIGHLIGHTS FROM DANIIL MEDVEDEV BEATING FLAVIO COBOLLI 7-6(4) 6-3 AT THE ATP FINALS…
CATL CEO ROBIN ZENG, AT APEC SHENZHEN: WE'RE INCREASING ENERGY DENSITY OF BATTERY TECHNOLOGY TO…
By Pritam Biswas Nov 16 (Reuters) - Institutional-investor enthusiasm for data-center stocks waned in the…
By Pritam Biswas Nov 16 (Reuters) - Institutional-investor enthusiasm for data-center stocks waned in the…
Nov 17 (Reuters) - Frontline Engineering Public Company Limited: * 9M REVENUE FROM SALES AND…
Gicarri Harris is the son of Glenn Robinson, one of the greatest players in Purdue…